Mesa Laboratories Stock Alpha and Beta Analysis
| MLAB Stock | USD 117.14 1.05 0.89% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Mesa Laboratories. It also helps investors analyze the systematic and unsystematic risks associated with investing in Mesa Laboratories over a specified time horizon. Remember, high Mesa Laboratories' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Mesa Laboratories' market risk premium analysis include:
Beta 3.07 | Alpha (0.56) | Risk 3.47 | Sharpe Ratio (0.01) | Expected Return (0.04) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Mesa |
Mesa Laboratories Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Mesa Laboratories market risk premium is the additional return an investor will receive from holding Mesa Laboratories long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Mesa Laboratories. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Mesa Laboratories' performance over market.| α | -0.56 | β | 3.07 |
Mesa Laboratories expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Mesa Laboratories' Buy-and-hold return. Our buy-and-hold chart shows how Mesa Laboratories performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Mesa Laboratories Market Price Analysis
Market price analysis indicators help investors to evaluate how Mesa Laboratories stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Mesa Laboratories shares will generate the highest return on investment. By understating and applying Mesa Laboratories stock market price indicators, traders can identify Mesa Laboratories position entry and exit signals to maximize returns.
Mesa Laboratories Return and Market Media
The median price of Mesa Laboratories for the period between Mon, Sep 2, 2024 and Sun, Dec 1, 2024 is 122.31 with a coefficient of variation of 7.81. The daily time series for the period is distributed with a sample standard deviation of 9.49, arithmetic mean of 121.42, and mean deviation of 7.6. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Acquisition by Sullivan John James of 1074 shares of Mesa Laboratories subject to Rule 16b-3 | 09/06/2024 |
2 | Disposition of 1499 shares by Brian Archbold of Mesa Laboratories at 125.0 subject to Rule 16b-3 | 09/13/2024 |
| Mesa Laboratories dividend paid on 16th of September 2024 | 09/16/2024 |
3 | Mesa Laboratories Inc Shares Up 4.12 percent on Sep 17 | 09/17/2024 |
4 | Royce Micro-Cap Trust as of Aug 31, 2024 | 09/27/2024 |
5 | Mesa Laboratories Inc Stock Price Down 4.63 percent on Oct 7 | 10/07/2024 |
6 | We Think Mesa Laboratories Can Stay On Top Of Its Debt | 10/17/2024 |
7 | Acquisition by Gary Owens of 11559 shares of Mesa Laboratories subject to Rule 16b-3 | 10/25/2024 |
8 | Disposition of 2518 shares by Gary Owens of Mesa Laboratories at 113.616 subject to Rule 16b-3 | 10/28/2024 |
9 | Disposition of 2551 shares by Gary Owens of Mesa Laboratories at 111.976 subject to Rule 16b-3 | 10/29/2024 |
10 | Mesa Laboratories CEO sells shares valued at 571,735 | 10/30/2024 |
11 | Mesa Labs Lags Q2 Earnings and Revenue Estimates | 11/07/2024 |
12 | Geneva Capital Management LLC Acquires 3,732 Shares of Mesa Laboratories, Inc. | 11/13/2024 |
13 | Disposition of 2000 shares by Sullivan John James of Mesa Laboratories subject to Rule 16b-3 | 11/19/2024 |
About Mesa Laboratories Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Mesa or other stocks. Alpha measures the amount that position in Mesa Laboratories has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.002513 | 0.003663 | 0.005714 | 0.005429 | Price To Sales Ratio | 7.21 | 4.24 | 2.79 | 2.94 |
Mesa Laboratories Upcoming Company Events
As portrayed in its financial statements, the presentation of Mesa Laboratories' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Mesa Laboratories' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Mesa Laboratories' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Mesa Laboratories. Please utilize our Beneish M Score to check the likelihood of Mesa Laboratories' management manipulating its earnings.
| 5th of February 2024 Upcoming Quarterly Report | View | |
| 23rd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 23rd of May 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of March 2023 Last Financial Announcement | View |
Build Portfolio with Mesa Laboratories
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Mesa Laboratories Backtesting, Mesa Laboratories Valuation, Mesa Laboratories Correlation, Mesa Laboratories Hype Analysis, Mesa Laboratories Volatility, Mesa Laboratories History and analyze Mesa Laboratories Performance. For information on how to trade Mesa Stock refer to our How to Trade Mesa Stock guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Mesa Laboratories technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.